title: Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation.
abstract: The EGF receptor has seven different cognate ligands. Previous work has shown that these different ligands are capable of inducing different biological effects, even in the same cell. To begin to understand the molecular basis for this variation, we used luciferase fragment complementation to measure ligand-induced dimer formation and radioligand binding to study the effect of the ligands on subunit-subunit interactions in EGF receptor (EGFR) homodimers and EGFR/ErbB2 heterodimers. In luciferase fragment complementation imaging studies, amphiregulin (AREG) functioned as a partial agonist, inducing only about half as much total dimerization as the other three ligands. However, unlike the other ligands, AREG showed biphasic kinetics for dimer formation, suggesting that its path for EGF receptor activation involves binding to both monomers and preformed dimers. EGF, TGFα, and betacellulin (BTC) appear to mainly stimulate receptor activation through binding to and dimerization of receptor monomers. In radioligand binding assays, EGF and TGFα exhibited increased affinity for EGFR/ErbB2 heterodimers compared with EGFR homodimers. By contrast, BTC and AREG showed a similar affinity for both dimers. Thus, EGF and TGFα are biased agonists, whereas BTC and AREG are balanced agonists with respect to selectivity of dimer formation. These data suggest that the differences in biological response to different EGF receptor ligands may result from partial agonism for dimer formation, differences in the kinetic pathway utilized to generate activated receptor dimers, and biases in the formation of heterodimers versus homodimers.
authors.affiliation: Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110.
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: Macdonald-Obermann
authors.affiliation: Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110. Electronic address: pike@biochem.wustl.edu.
authors.forename: Linda J
authors.initials: LJ
authors.lastname: Pike
mesh_terms: D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology; D001665:Binding Sites; D016466:CHO Cells; D000068818:Cetuximab; D006224:Cricetinae; D003412:Cricetulus; D066246:ErbB Receptors / Q000819:agonists / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D008024:Ligands; D055503:Protein Multimerization; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D015398:Signal Transduction; D015533:Transcriptional Activation
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000068818:Cetuximab; D066246:ErbB Receptors; D008024:Ligands; D018719:Erb-b2 Receptor Tyrosine Kinases; C512478:EGFR protein, human; C508053:ERBB2 protein, human; C485206:pertuzumab
keywords: Amphiregulin; Betacellulin; Epidermal Growth Factor (EGF); Growth Factor; Protein-Tyrosine Kinase (Tyrosine Kinase); Receptor Structure-Function; Receptor Tyrosine Kinase; Signal Transduction; Transforming Growth Factor α (TGF-α)
references.citation: Nat Rev Cancer. 2005 May;5(5):341-54
references.pmid: 15864276
references.citation: Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1500-4
references.pmid: 7509075
references.citation: Cell. 2010 Jun 25;141(7):1117-34
references.pmid: 20602996
references.citation: Nature. 1984 May 31-Jun 6;309(5967):418-25
references.pmid: 6328312
references.citation: J Biol Chem. 2013 Oct 18;288(42):30773-30784
references.pmid: 24014028
references.citation: Mol Cell Biol. 1996 Oct;16(10):5276-87
references.pmid: 8816440
references.citation: Exp Cell Res. 2007 Feb 15;313(4):732-41
references.pmid: 17196962
references.citation: Structure. 2008 Mar;16(3):460-7
references.pmid: 18334220
references.citation: J Biol Chem. 1999 Mar 26;274(13):8865-74
references.pmid: 10085130
references.citation: Biochem J. 1989 Sep 1;262(2):659-63
references.pmid: 2803273
references.citation: J Biol Chem. 2011 May 27;286(21):18756-65
references.pmid: 21454582
references.citation: Cell. 2009 Jun 26;137(7):1293-307
references.pmid: 19563760
references.citation: Cell. 1990 Jun 29;61(7):1339-47
references.pmid: 1973074
references.citation: J Biol Chem. 2009 Mar 20;284(12):7474-82
references.pmid: 19171934
references.citation: J Biol Chem. 2012 Sep 7;287(37):31116-25
references.pmid: 22822073
references.citation: Cell. 2006 Jun 16;125(6):1137-49
references.pmid: 16777603
references.citation: Endocrinology. 2004 Sep;145(9):4232-43
references.pmid: 15192046
references.citation: Cell. 2002 Sep 20;110(6):775-87
references.pmid: 12297050
references.citation: Annu Rev Biophys. 2008;37:353-73
references.pmid: 18573086
references.citation: Cell. 2002 Sep 20;110(6):763-73
references.pmid: 12297049
references.citation: Proc Natl Acad Sci U S A. 2012 Jan 3;109(1):137-42
references.pmid: 22190492
references.citation: Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):112-7
references.pmid: 18165319
references.citation: Mol Biol Cell. 1994 Jul;5(7):739-46
references.pmid: 7812043
references.citation: J Immunol Methods. 1980;39(1-2):155-63
references.pmid: 7462645
references.citation: Biochem J. 2008 Mar 15;410(3):585-94
references.pmid: 18045238
references.citation: Growth Factors. 2012 Apr;30(2):107-16
references.pmid: 22260327
references.citation: Mol Cell. 2003 Feb;11(2):507-17
references.pmid: 12620237
references.citation: J Biol Chem. 1989 Jun 25;264(18):10667-71
references.pmid: 2543678
references.citation: Pharmacol Ther. 2009 Apr;122(1):1-8
references.pmid: 19135477
references.citation: EMBO J. 1997 Apr 1;16(7):1647-55
references.pmid: 9130710
references.citation: FEBS Lett. 1999 Mar 26;447(2-3):227-31
references.pmid: 10214951
references.citation: Growth Factors. 2008 Oct;26(5):263-74
references.pmid: 18800267
references.citation: Nature. 1984 Oct 4-10;311(5985):483-5
references.pmid: 6090945
references.citation: Mol Cancer Res. 2007 Aug;5(8):847-61
references.pmid: 17670913
references.citation: Mol Biol Cell. 2005 Dec;16(12):5832-42
references.pmid: 16207817
references.citation: EMBO J. 1996 Jan 15;15(2):254-64
references.pmid: 8617201